CRISPR study silences gene mutations that drive aggressive cancers

byPeter MacCallum Cancer CentreMolecular principles of CRISPR-Cas13 mismatch intolerance enable selective silencing of point-mutated oncogenic RNA with single-base precision. Credit:Scienc

Updated on: January 21,2025

CRISPR study silences gene mutations that drive aggressive cancers

byPeter MacCallum Cancer CentreMolecular principles of CRISPR-Cas13 mismatch intolerance enable selective silencing of point-mutated oncogenic RNA with single-base precision. Credit:Scienc

Updated on:January 21,2025

Breast cancer risk increases with weight gain after age 35, finds study

by Elana GotkineThe risk for breast cancer is increased with weight gain after age 35 years, according to a research letter recentlypublishedinCancer Biology & Medicine.Katherine

Updated on: January 21,2025

Breast cancer risk increases with weight gain after age 35, finds study

by Elana GotkineThe risk for breast cancer is increased with weight gain after age 35 years, according to a research letter recentlypublishedinCancer Biology & Medicine.Katherine

Updated on:January 21,2025

Abnormal prenatal blood test results could indicate hidden maternal cancers

byNIH/Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentCredit: Josh Willink from PexelsResearchers at the National Institutes of Health (NIH) found previously undet

Updated on: December 20,2024

Abnormal prenatal blood test results could indicate hidden maternal cancers

byNIH/Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentCredit: Josh Willink from PexelsResearchers at the National Institutes of Health (NIH) found previously undet

Updated on:December 20,2024

Building better biomaterials for cancer treatments

Updated on: March 09,2025

Building better biomaterials for cancer treatments

Updated on:March 09,2025

Could a pill replace gene therapy for sickle cell disease? Research uncovers potential path to small-molecule drug

by Nancy Fliesler,Children's Hospital BostonNew work suggests ways to target the BCL11A protein with drugs, enabling patients with sickle cell disease to produce non-sickling fetal hemoglobi

Updated on: January 17,2025

Could a pill replace gene therapy for sickle cell disease? Research uncovers potential path to small-molecule drug

by Nancy Fliesler,Children's Hospital BostonNew work suggests ways to target the BCL11A protein with drugs, enabling patients with sickle cell disease to produce non-sickling fetal hemoglobi

Updated on:January 17,2025

Oncologist discusses treating liver cancer

by Mayo Clinic News NetworkCredit: Pixabay/CC0 Public DomainLiver cancer rates have more than tripled in the U.S. since 1980 and continue to rise. More than 41,000 people will be diagnosed with liver

Updated on: January 21,2025

Oncologist discusses treating liver cancer

by Mayo Clinic News NetworkCredit: Pixabay/CC0 Public DomainLiver cancer rates have more than tripled in the U.S. since 1980 and continue to rise. More than 41,000 people will be diagnosed with liver

Updated on:January 21,2025

How breast cancer cells survive in bone marrow after remission

byUniversity of MichiganGraphical abstract. Credit:Journal of Clinical Investigation(2024). DOI: 10.1172/JCI170953A study from researchers at the University of Michigan and the Unive

Updated on: December 21,2024

How breast cancer cells survive in bone marrow after remission

byUniversity of MichiganGraphical abstract. Credit:Journal of Clinical Investigation(2024). DOI: 10.1172/JCI170953A study from researchers at the University of Michigan and the Unive

Updated on:December 21,2024

Adding polyvinyl alcohol to a boron-containing drug leads to strong antitumor activity in head and neck cancers

byUniversity of TokyoCancer cell during cell division. Credit: National Institutes of HealthTreatment for more advanced and difficult-to-treat head and neck cancers can be improved with the addi

Updated on: December 21,2024

Adding polyvinyl alcohol to a boron-containing drug leads to strong antitumor activity in head and neck cancers

byUniversity of TokyoCancer cell during cell division. Credit: National Institutes of HealthTreatment for more advanced and difficult-to-treat head and neck cancers can be improved with the addi

Updated on:December 21,2024

Neurocognitive battery feasible in 3-year-olds during leukemia treatment

by Elana GotkineA brief neurocognitive battery is feasible for use in 3-year-olds during acute lymphoblastic leukemia treatment, according to a studypublishedonline Dec. 9 inPediatri

Updated on: January 22,2025

Neurocognitive battery feasible in 3-year-olds during leukemia treatment

by Elana GotkineA brief neurocognitive battery is feasible for use in 3-year-olds during acute lymphoblastic leukemia treatment, according to a studypublishedonline Dec. 9 inPediatri

Updated on:January 22,2025

Machine learning uncovers three osteosarcoma subtypes for targeted treatment

byUniversity of East AngliaLatent process decomposition model optimization, subtype assignment and clinical outcome. Credit:Briefings in Bioinformatics(2024). DOI: 10.1093/bib/bbae66

Updated on: January 21,2025

Machine learning uncovers three osteosarcoma subtypes for targeted treatment

byUniversity of East AngliaLatent process decomposition model optimization, subtype assignment and clinical outcome. Credit:Briefings in Bioinformatics(2024). DOI: 10.1093/bib/bbae66

Updated on:January 21,2025

Cancer risk declines in old age: New research helps explain why

by Ian Demsky,Memorial Sloan Kettering Cancer CenterAged AT2 cells exhibit reduced cell-intrinsic potential for regeneration and tumorigenesis. Credit:Nature(2024). DOI: 10.1038/s415

Updated on: December 21,2024

Cancer risk declines in old age: New research helps explain why

by Ian Demsky,Memorial Sloan Kettering Cancer CenterAged AT2 cells exhibit reduced cell-intrinsic potential for regeneration and tumorigenesis. Credit:Nature(2024). DOI: 10.1038/s415

Updated on:December 21,2024

Immunosuppression study helps understand why some prostate cancer treatments do not work as expected

byTampere UniversityOn the left is a tissue sample from the prostate stained with hematoxylin and eosin. Hematoxylin stains the nuclei blue or purple because it binds to DNA, and eosin stains th

Updated on: December 21,2024

Immunosuppression study helps understand why some prostate cancer treatments do not work as expected

byTampere UniversityOn the left is a tissue sample from the prostate stained with hematoxylin and eosin. Hematoxylin stains the nuclei blue or purple because it binds to DNA, and eosin stains th

Updated on:December 21,2024